Health Canada drug identification number

DIN 02456257 — SANDOZ MIGLUSTAT 100 MG

SANDOZ MIGLUSTAT is a capsule of Miglustat marketed by SANDOZ CANADA INCORPORATED. The full Miglustat monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02456257
Brand name
SANDOZ MIGLUSTAT
Active ingredient
Miglustat
Strength
100 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
SANDOZ CANADA INCORPORATED
Health Canada status
MARKETED
Drug class
Glucosylceramide synthase inhibitor (substrate reduction therapy)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Miglustat products

DINBrandStrengthFormManufacturerStatus
02556812 OPFOLDA 65 MG CAPSULE AMICUS THERAPEUTICS CANADA INC. MARKETED
02250519 ZAVESCA 100 MG CAPSULE JANSSEN INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.